Skip Nav Destination
Issues
1 December 2013
-
Cover Image
Cover Image
![issue cover]()
The cover shows a human U251-MG glioblastoma cell transfected with 100 nM of non-target siRNA. Phalloidin (green) and DAPI (blue) staining shows organized F-actin and cell morphology. For details, see the article by Zheng and colleagues on page 6484 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR New Strategies
Molecular Pathways
CCR Focus
Human Cancer Biology
Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study
Jiping Wang; Luis G. Carvajal-Carmona; Jen-Hwa Chu; Ann G. Zauber; APC Trial Collaborators; Michikai Kubo; Koichi Matsuda; Malcolm Dunlop; Richard S. Houlston; Oliver Sieber; Lara Lipton; Peter Gibbs; Nicholas G. Martin; Grant W. Montgomery; Joanne Young; Paul N. Baird; Mark J. Ratain; Yusuke Nakamura; Scott T. Weiss; Ian Tomlinson; Monica M. Bertagnolli
Contrasting Expression Patterns of Histone mRNA and microRNA 760 in Patients with Gastric Cancer
Takeshi Iwaya; Takeo Fukagawa; Yutaka Suzuki; Yusuke Takahashi; Genta Sawada; Masahisa Ishibashi; Junji Kurashige; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Fumitaka Endo; Hirokatsu Katagiri; Kaoru Ishida; Kohei Kume; Satoshi Nishizuka; Hisae Iinuma; Go Wakabayashi; Masaki Mori; Mitsuru Sasako; Koshi Mimori
Cancer Therapy: Preclinical
Author Choice
A Genetically Engineered Oncolytic Adenovirus Decoys and Lethally Traps Quiescent Cancer Stem–like Cells in S/G2/M Phases
Shuya Yano; Hiroshi Tazawa; Yuuri Hashimoto; Yasuhiro Shirakawa; Shinji Kuroda; Masahiko Nishizaki; Hiroyuki Kishimoto; Futoshi Uno; Takeshi Nagasaka; Yasuo Urata; Shunsuke Kagawa; Robert M. Hoffman; Toshiyoshi Fujiwara
The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Marion A. Salvador; Julien Wicinski; Olivier Cabaud; Yves Toiron; Pascal Finetti; Emmanuelle Josselin; Hélène Lelièvre; Laurence Kraus-Berthier; Stéphane Depil; François Bertucci; Yves Collette; Daniel Birnbaum; Emmanuelle Charafe-Jauffret; Christophe Ginestier
Targeting Src and Tubulin in Mucinous Ovarian Carcinoma
Tao Liu; Wei Hu; Heather J. Dalton; Hyun Jin Choi; Jie Huang; Yu Kang; Sunila Pradeep; Takahito Miyake; Jian H. Song; Yunfei Wen; Chunhua Lu; Chad V. Pecot; Justin Bottsford-Miller; Behrouz Zand; Nicholas B. Jennings; Cristina Ivan; Gary E. Gallick; Keith A. Baggerly; David G. Hangauer; Robert L. Coleman; Michael Frumovitz; Anil K. Sood
Imaging, Diagnosis, Prognosis
Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer
Joo Mi Yi; Angela A. Guzzetta; Vasudev J. Bailey; Stephanie R. Downing; Leander Van Neste; Katherine B. Chiappinelli; Brian P. Keeley; Alejandro Stark; Alexander Herrera; Christopher Wolfgang; Emmanouil P. Pappou; Christine A. Iacobuzio-Donahue; Michael G. Goggins; James G. Herman; Tza-Huei Wang; Stephen B. Baylin; Nita Ahuja
EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma
Carmen Behrens; Luisa M. Solis; Heather Lin; Ping Yuan; Ximing Tang; Humam Kadara; Erick Riquelme; Hector Galindo; Cesar A. Moran; Neda Kalhor; Stephen G. Swisher; George R. Simon; David J. Stewart; J. Jack Lee; Ignacio I. Wistuba
Cancer Therapy: Clinical
A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)
Patrick A. Thompson; Rachid Drissi; Jodi A. Muscal; Eshini Panditharatna; Maryam Fouladi; Ashish M. Ingle; Charlotte H. Ahern; Joel M. Reid; Tong Lin; Brenda J. Weigel; Susan M. Blaney
Author Choice
Photodynamic Therapy with 3-(1′-Hexyloxyethyl) Pyropheophorbide a for Cancer of the Oral Cavity
Nestor Rigual; Gal Shafirstein; Michele T. Cooper; Heinz Baumann; David A. Bellnier; Ulas Sunar; Erin C. Tracy; Daniel J. Rohrbach; Gregory Wilding; Wei Tan; Maureen Sullivan; Mihai Merzianu; Barbara W. Henderson
A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
Andrew X. Zhu; Richard S. Finn; Mary Mulcahy; Jayne Gurtler; Weijing Sun; Jonathan D. Schwartz; Rita P. Dalal; Adarsh Joshi; Rebecca R. Hozak; Yihuan Xu; Marek Ancukiewicz; Rakesh K. Jain; Francis W. Nugent; Dan G. Duda; Keith Stuart
Predictive Biomarkers and Personalized Medicine
A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab
Oliver W. Press; Joseph M. Unger; Lisa M. Rimsza; Jonathan W. Friedberg; Michael LeBlanc; Myron S. Czuczman; Mark Kaminski; Rita M. Braziel; Catherine Spier; Ajay K. Gopal; David G. Maloney; Bruce D. Cheson; Shaker R. Dakhil; Thomas P. Miller; Richard I. Fisher
Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
Ranee Mehra; Fang Zhu; Dong-Hua Yang; Kathy Q. Cai; JoEllen Weaver; Mahendra K. Singh; Anna S. Nikonova; Erica A. Golemis; Douglas B. Flieder; Harry S. Cooper; Miriam Lango; John A. Ridge; Barbara Burtness
Advertisement
